Clinical Trials · NCT06299098
A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation
- Phase
- Phase 2
- Recruitment status
- Active Not Recruiting
- Sponsor
- Regeneron Pharmaceuticals
- Enrollment
- 1,005
- Start date
- Mar 2024
- Locations
- 60 sites, United States, Puerto Rico
- Primary endpoint
- Incidence of treatment-emergent adverse events (TEAEs)